Market Overview

UPDATE: Deutsche Bank Upgrades Team Health Following Q2 Wake-Up Call

Related TMH
Benzinga's Top Initiations
Benzinga's M&A Chatter for Monday November 2, 2015
CRH Medical: Rapid Growth Due To Acquisitions Just Getting Started (Seeking Alpha)

In a report published Thursday, Deutsche Bank analyst Darren Lehrich upgraded the rating on Team Health (NYSE: TMH) from Hold to Buy, and raised the price target from $57.00 to $63.00.

In the report, Deutsche Bank noted, “We believe this past Q2 earnings season has served as a wake-up call for investors vis-a-vis the health care provider names most levered to the ACA investment theme: hospitals and physician outsourcing co's. While this sub-set of co's is up 26.6% YTD vs. 4% for the S&P 500, we believe the stocks can continue to outperform based on the combination of: (1) ACA benefits still ramping; and (2) core trends starting to show signs of fundamental strength. As such, we maintain our overweight positioning on all 5 of the investor-owned hospital co's, and we return to Buy from Hold on TMH given our view that better organic growth can over-power higher churn over the N-T.”

Team Health closed on Wednesday at $55.93.

Latest Ratings for TMH

Jan 2016JefferiesMaintainsAction List BuyBuy
Dec 2015BairdDowngradesOutperformNeutral
Dec 2015Mizuho SecuritiesInitiates Coverage onNeutral

View More Analyst Ratings for TMH
View the Latest Analyst Ratings

Posted-In: Darren Lehrich Deutsche BankAnalyst Color Upgrades Analyst Ratings


Related Articles (TMH)

View Comments and Join the Discussion!

Get Benzinga's Newsletters